These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33050864)

  • 41. Target Enzyme in Alzheimer's Disease: Acetylcholinesterase Inhibitors.
    Saxena M; Dubey R
    Curr Top Med Chem; 2019; 19(4):264-275. PubMed ID: 30706815
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Design of acetylcholinesterase inhibitor for Alzheimer's disease therapy: from multi-binding site inhibitors to multi-target directed ligands].
    Yang WC; Sun Q; Yu NX; Zhu XL; Yang GF
    Yao Xue Xue Bao; 2012 Mar; 47(3):313-21. PubMed ID: 22645754
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In silico Screening of Pyridoxine Carbamates for Anti-Alzheimer's Activities.
    Baswar D; Sharma A; Mishra A
    Cent Nerv Syst Agents Med Chem; 2021; 21(1):39-52. PubMed ID: 33213353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
    Thiratmatrakul S; Yenjai C; Waiwut P; Vajragupta O; Reubroycharoen P; Tohda M; Boonyarat C
    Eur J Med Chem; 2014 Mar; 75():21-30. PubMed ID: 24508831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improving Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Are Irreversible Inhibitors the Future?
    Moss DE
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32414155
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TV 3326 for Alzheimer's dementia: a novel multimodal ChE and MAO inhibitors to mitigate Alzheimer's-like neuropathology.
    Uddin MS; Kabir MT; Rahman MM; Mathew B; Shah MA; Ashraf GM
    J Pharm Pharmacol; 2020 Aug; 72(8):1001-1012. PubMed ID: 32149402
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phthalimide-(N-alkylbenzylamine) cysteamide hybrids as multifunctional agents against Alzheimer's disease: Design, synthesis, and biological evaluation.
    Zhang H; Song Q; Yu G; Cao Z; Qiang X; Liu X; Deng Y
    Chem Biol Drug Des; 2021 Oct; 98(4):493-500. PubMed ID: 34143938
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cystamine-tacrine dimer: a new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment.
    Minarini A; Milelli A; Tumiatti V; Rosini M; Simoni E; Bolognesi ML; Andrisano V; Bartolini M; Motori E; Angeloni C; Hrelia S
    Neuropharmacology; 2012 Feb; 62(2):997-1003. PubMed ID: 22032870
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
    Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V
    ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A molecular approach in drug development for Alzheimer's disease.
    Agatonovic-Kustrin S; Kettle C; Morton DW
    Biomed Pharmacother; 2018 Oct; 106():553-565. PubMed ID: 29990843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines.
    Romero A; Marco-Contelles J
    Curr Top Med Chem; 2017; 17(31):3328-3335. PubMed ID: 29332586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interest of novel N-alkylpyridinium-indolizine hybrids in the field of Alzheimer's disease: Synthesis, characterization and evaluation of antioxidant activity, cholinesterase inhibition, and amyloid fibrillation interference.
    Baussanne I; Firstova O; Dediu AB; Larosa C; Furdui B; Ghinea IO; Thomas A; Chierici S; Dinica R; Demeunynck M
    Bioorg Chem; 2021 Nov; 116():105390. PubMed ID: 34670332
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of natural products for the treatment of Alzheimer's disease.
    Noori T; Dehpour AR; Sureda A; Sobarzo-Sanchez E; Shirooie S
    Eur J Pharmacol; 2021 May; 898():173974. PubMed ID: 33652057
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands.
    Iraji A; Khoshneviszadeh M; Firuzi O; Khoshneviszadeh M; Edraki N
    Bioorg Chem; 2020 Apr; 97():103649. PubMed ID: 32101780
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural Scaffolds with Multi-Target Activity for the Potential Treatment of Alzheimer's Disease.
    Piemontese L; Vitucci G; Catto M; Laghezza A; Perna FM; Rullo M; Loiodice F; Capriati V; Solfrizzo M
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30158491
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of anti-Alzheimer agents: current ligand-based approaches toward the design of acetylcholinesterase inhibitors.
    Speck-Planche A; Luan F; Cordeiro MN
    Mini Rev Med Chem; 2012 Jun; 12(6):583-91. PubMed ID: 22587771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and Evaluation of Novel Ligustrazine Derivatives as Multi-Targeted Inhibitors for the Treatment of Alzheimer's Disease.
    Wu W; Liang X; Xie G; Chen L; Liu W; Luo G; Zhang P; Yu L; Zheng X; Ji H; Zhang C; Yi W
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30301153
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chromones: privileged scaffolds for the production of multi-target-directed-ligand agents for the treatment of Alzheimer's disease.
    Silva CFM; Pinto DCGA; Silva AMS
    Expert Opin Drug Discov; 2018 Dec; 13(12):1141-1151. PubMed ID: 30430870
    [No Abstract]   [Full Text] [Related]  

  • 59. Potent Acetylcholinesterase Inhibitors: Potential Drugs for Alzheimer's Disease.
    Akıncıoğlu H; Gülçin İ
    Mini Rev Med Chem; 2020; 20(8):703-715. PubMed ID: 31902355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and characterization of 1H-phenanthro[9,10-d]imidazole derivatives as multifunctional agents for treatment of Alzheimer's disease.
    Liu J; Qiu J; Wang M; Wang L; Su L; Gao J; Gu Q; Xu J; Huang SL; Gu LQ; Huang ZS; Li D
    Biochim Biophys Acta; 2014 Sep; 1840(9):2886-903. PubMed ID: 24821011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.